Abstract
Autism is a biologically-heterogeneous disease. Distinct subgroups of autistic patients may be marked by intermediate phenotypes, such as elevated serotonin (5-HT) blood levels, potentially associated with different underlying disease mechanisms. This could lead to inconsistent genetic association results, such as those of prior studies on serotonin transporter (5-HTT) gene promoter variants and autistic disorder. Contributions of 5-HTT gene promoter alleles to 5-HT blood levels were thus investigated in 134 autistic patients and 291 first-degree relatives. Mean 5-HT blood levels are 11% higher in autistic patients carrying the L/L genotype, compared to patients with the S/S or S/L genotype; this trend is not observed in first-degree relatives. The probability of inheriting L or S alleles is significantly enhanced in patients with 5-HT blood levels above or below the mean, respectively (P < 0.05), but quantitative TDT analyses yield a non-significant trend (P = 0.10), as this polymorphism explains only 2.5% of the variance in 5-HT blood levels of autistic patients. In conclusion, 5-HTT gene promoter variants seemingly exert a small effect on 5-HT blood levels in autistic children, which largely does not account for hyperserotoninemia. Nonetheless, the inconsistent outcome of prior association studies could partly stem from a selection bias of hyper- or hypo-serotoninemic probands.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cook EH Jr, Courchesne R, Lord C, Cox NJ, Yan S, Lincoln A et al. Evidence of linkage between the serotonin transporter and autistic disorder Mol Psychiatry 1997; 2: 247–250
Klauck SM, Poustka F, Benner A, Lesch KP, Poutska A . Serotonin transporter (5-HTT) gene variants associated with autism? Hum Mol Genet 1997; 6: 2233–2238
Tordjman S, Gutneckt L, Carlier M, Spitz E, Antoine C, Slama F et al. Role of the serotonin transporter in the behavioral expression of autism Mol Psychiatry 2001; 6: 434–439
Yirmiya N, Pilowsky T, Nemanov L, Arbelle S, Feinsilver T, Fried I et al. Evidence for an association with the serotonin transporter promoter region polymorphism and autism Am J Med Genet 2001; 105: 381–386
Maestrini E, Lai C, Marlow A, Matthews N, Wallace S, Bailey A et al. Serotonin transporter (5-HTT) and γ-aminobutyric acid receptor subunit γ3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families Am J Med Genet 1999; 88: 492–496
Persico AM, Militerni R, Bravaccio C, Schneider C, Melmed R, Conciatori M et al. Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically-distinct samples Am J Med Genet 2000; 96: 123–127
Cook EH Jr, Leventhal B . The serotonin system in autism Curr Opin Pediat 1996; 8: 348–354
Piven J, Tsai G, Nehme E, Coyle JT, Chase GA, Folstein SE . Platelet serotonin, a possible marker for familial autism J Autism DevDisord 1991; 21: 51–59
Katsui T, Okuda M, Usuda S, Koizumi T . Kinetics of 3H-serotonin uptake by platelets in infantile autism and developmental language disorder (including five pairs of twins) J Autism Dev Disord 1986; 16: 69–76
Marazziti D, Muratori F, Cesari A, Masala I, Baroni S, Giannaccini G et al. Increased density of the platelet serotonin transporter in autism Pharmacopsychiatry 2000; 33: 165–168
Cook EH Jr, Leventhal BL, Freedman DX . Free serotonin in plasma: autistic children and their first-degree relatives Biol Psychiatry 1988; 24: 488–491
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region Science 1996; 274: 1527–1531
Greenberg BD, Tolliver TJ, Huang S-J, Li Q, Bengel D, Murphy DL . Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets Am J Med Genet 1999; 88: 83–87
Nobile M, Begni B, Giorda R, Frigerio A, Marino C, Molteni M et al. Effects of serotonin transporter promoter genotype on platelet serotonin transporter functionality in depressed children and adolescents J Am Acad Child Adolesc Psychiatry 1999; 38: 1396–1402
Hérault J, Petit E, Martineau J, Cherpi C, Perrot A, Barthélémy C et al. Serotonin and autism: biochemical and molecular biology features Psychiatry Res 1996; 65: 33–43
Yang Q, Rabinowitz D, Isasi C, Shea S . Adjusting for confounding due to population admixture when estimating the effect of candidate genes on quantitative traits Hum Hered 2000; 50: 227–233
McBride PA, Anderson G, Hertzig ME, Snow ME, Thompson SM, Khait VD et al. Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation J Am Acad Child Adolesc Psychiatry 1998; 37: 767–776
Leboyer M, Philippe A, Bouvard M, Guilloud-Bataille M, Bondoux D, Tabuteau F et al. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives Biol Psychiatry 1999; 45: 158–163
Persico AM, Militerni R, Bravaccio C, Schneider C, Melmed R, Trillo S et al. Adenosine deaminase (ADA) alleles and autistic disorder: case-control and family-based association studies Am J Med Genet 2000; 96: 784–790
Chugani DC, Muzik O . γ[11C]methyl-L-tryptophan PET maps brain serotonin synthesis and kynurenine pathway metabolism J Cereb Blood Flow Metab 2000; 20: 2–9
Croonenberghs J, Delmerie L, Verkerk R, Lin A-H, Meskal A, Neels H et al. Peripheral markers of serotoninergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder Neuropsychopharmacology 2000; 22: 275–283
Pedersen OS, Liu Y, Reichelt KL . Serotonin uptake stimulating peptide found in plasma of normal individuals and in some autistic urines J Peptide Res 1999; 53: 641–646
Keller F, Persico AM, Baldi A, Reichelt K-L, Gonzalez A . Serotonin uptake-stimulating peptides extracted from the urines of autistic patients: potential significance for the pathogenesis of autistic disorder Soc Neurosci Abs 1998; 24: 227
Militerni R, Bravaccio C, Falco C, Puglisi-Allegra S, Pascucci T, Fico C . Pain reactivity in children with autistic disorder J Headache Pain 2000; 1: 53–56
Ramamoorthy S, Blakely RD . Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants Science 1999; 285: 763–766
Marazziti D, Rossi A, Masala I, Rotondo A, Palego L, Mazzoni M et al. Regulation of the platelet serotonin transporter by protein kinase C in the young and elderly Biol Psychiatry 1999; 45: 443–447
Barman AL, Apparsundaram S, Ramamoorthy S, Wadsinski BE, Vaughan RA, Blakely RD . Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A J Neurosci 2000; 20: 7571–7578
Persico AM, D'Agruma L, Maiorano N, Totaro A, Militerni R, Bravaccio C et al. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder Mol Psychiatry 2001; 6: 150–159
Spielman RS, Ewens WJ . The TDT and other family-based tests for linkage disequilibrium and association Am J Hum Genet 1996; 59: 983–989
Terwilliger JD, Ott J . A haplotype-based ‘haplotype relative risk’ approach to detecting allelic associations Hum Hered 1992; 42: 337–346
Acknowledgements
The authors are very grateful to the families who participated in this study. We also thank Rossella Ventura for collaborating on HPLC analyses. This work was funded by the European Community (Biomed-2 grant BMH4-CT96–0730), and by the Italian Ministry of Health (grant ICS.190.1.RF99/90), and by a grant from the National Alliance for Autism Research (NAAR).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Persico, A., Pascucci, T., Puglisi-Allegra, S. et al. Serotonin transporter gene promoter variants do not explain the hyperserotoninemia in autistic children. Mol Psychiatry 7, 795–800 (2002). https://doi.org/10.1038/sj.mp.4001069
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001069
Keywords
This article is cited by
-
Autism genetics: Methodological issues and experimental design
Science China Life Sciences (2015)
-
Association study in siblings and case-controls of serotonin- and oxytocin-related genes with high functioning autism
Journal of Molecular Psychiatry (2014)
-
Relationships among body mass, brain size, gut length, and blood tryptophan and serotonin in young wild-type mice
BMC Physiology (2009)
-
Involvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expression
Molecular Psychiatry (2009)
-
Origin of the blood hyperserotonemia of autism
Theoretical Biology and Medical Modelling (2008)